Acadia Healthcare (NASDAQ:ACHC – Get Free Report) announced its earnings results on Wednesday. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01, Briefing.com reports. Acadia Healthcare had a positive return on equity of 11.42% and a negative net margin of 0.17%. The firm had revenue of $815.60 million during the quarter, compared to analysts’ expectations of $819.42 million. During the same quarter in the prior year, the business earned $0.91 earnings per share. The company’s revenue was up 8.7% on a year-over-year basis. Acadia Healthcare updated its FY24 guidance to $3.35-$3.45 EPS and its FY 2024 guidance to 3.350-3.450 EPS.
Acadia Healthcare Stock Performance
Shares of NASDAQ ACHC traded down $8.80 during trading hours on Thursday, reaching $43.28. The stock had a trading volume of 3,385,295 shares, compared to its average volume of 962,583. Acadia Healthcare has a twelve month low of $42.56 and a twelve month high of $87.77. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.18 and a quick ratio of 1.18. The business’s fifty day moving average is $67.15 and its two-hundred day moving average is $68.18. The company has a market cap of $4.02 billion, a price-to-earnings ratio of -312.36, a PEG ratio of 1.57 and a beta of 1.29.
Wall Street Analyst Weigh In
A number of research analysts recently issued reports on ACHC shares. Barclays lowered their target price on shares of Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating on the stock in a research note on Monday, September 30th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $94.00 price target on shares of Acadia Healthcare in a research report on Friday, September 20th. Deutsche Bank Aktiengesellschaft boosted their price objective on Acadia Healthcare from $70.00 to $75.00 and gave the stock a “hold” rating in a research report on Friday, August 2nd. KeyCorp assumed coverage on Acadia Healthcare in a report on Friday, October 11th. They issued a “sector weight” rating on the stock. Finally, Cantor Fitzgerald reiterated a “neutral” rating and set a $90.00 price target on shares of Acadia Healthcare in a report on Tuesday, October 1st. One analyst has rated the stock with a sell rating, four have assigned a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $86.67.
About Acadia Healthcare
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Read More
- Five stocks we like better than Acadia Healthcare
- Conference Calls and Individual Investors
- Microsoft Can Hit New All-Time Highs This Year – Here’s Why
- Most active stocks: Dollar volume vs share volume
- Zillow Stock’s Bull Case: Why This Recent Sell-Off Could Be a Buy
- What is the Dogs of the Dow Strategy? Overview and Examples
- IonQ’s Quantum Surge: Ride the Wave or Cash Out?
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.